Search clinical trials for: MGN-3

Total 18402 results

Franklin Pierce University

Completed

Interrupting Sitting Time During Postprandial State

Sedentary Behavior

United States
MGB Biopharma Limited
Hammersmith Medicines Research; Innovate UK; Cambridge Regulatory Services; Phases... and other collaborators

Completed

Safety, Blood Levels and Effects of MGB-BP-3

Healthy
Novo Nordisk A/S

Completed

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

Diabetes Mellitus, Type 2

Germany
Zagazig University
University of California, Irvine; Charles Drew University of Medicine and Science and other collaborators

Completed

Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses

Influenza-like Illness

Egypt
Autoimmune Technologies, LLC

Completed

Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects

Influenza

United States
University College, London

Active, not recruiting

Semaglutide 2.4 mg in Patients With Poor Weight-loss (BARI-STEP)

Obesity | Diabetes | Metabolic Syndrome

United Kingdom
Albireo

Completed

An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects

Primary Biliary Cirrhosis | Alagille Syndrome | Progressive Familial Intrahepatic Cholestasis | Orphan Cholestatic Liver Diseases

United Kingdom
Bial - Portela C S.A.

Completed

Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites

Parkinson's Disease

Switzerland
Serum Institute of India Pvt. Ltd.
PPD

Completed

Safety Study of Dengushield in Healthy Adults

Dengue | Phase 1

Australia
Region Skane

Completed

The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery (AIR)

Systemic Inflammatory Response Syndrome | Pancreatic Neoplasms | Hypovolemia | Urogenital Neoplasm

Sweden
University of Colorado, Denver
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Alcohol Use Disorder

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Withdrawn

Reducing Sedentary Time in Obese Adults (Study 2) (B-MOBILE)

Obesity

United States
Otonomy, Inc.

Completed

OTO-104 for Meniere's Disease

Meniere's Disease

United States
National Cancer Institute (NCI)

Completed

Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection

Acquired Immunodeficiency Syndrome | HIV Infection

United States
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

Diabetic Neuropathy

United States
Clinical Research Centre, Malaysia
Twin Catalyst Sdn. Bhd.; Sarawak Research Society

Completed

A Pilot Functional Performances Study of Two Synthetic Male Condom (WONDALEAF-MEN)

Functional Performance | Synthetic Male Condom

Malaysia
Sansum Diabetes Research Institute
Novo Nordisk A/S

Terminated

Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Diabetes Mellitus, Type 2 | Glucose Metabolism Disorders (Including Diabetes Mellitus)

United States
Alcon Research

Completed

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration
aTyr Pharma, Inc.
Kyorin Pharmaceutical Co.,Ltd

Recruiting

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States, Japan, Netherlands, Spain, United Kingdom, France, Italy, Brazil, Germany, Puerto Rico
UroGen Pharma Ltd.

Completed

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Neoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms

India
Pfizer

Completed

A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers

Healthy

United States
Signe Torekov
Karolinska Institutet; Rigshospitalet, Denmark; University of Leeds; Holbaek Sygehus

Recruiting

Young Adults With Early-onset Obesity Treated With Semaglutide (RESETTLE)

Obesity, Adolescent

Denmark
Novartis Pharmaceuticals

Completed

A First-in-Human Study of CEE321 in Adult Subjects

Atopic Dermatitis

United States, Japan
MediciNova

Completed

Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
H. Lundbeck A/S

Terminated

Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia

Schizophrenia

Bulgaria, Czechia, Estonia, Germany, Hungary, Latvia, Poland, Ukraine
GlaxoSmithKline

Completed

A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects (DEMAND I)

Muscular Dystrophies

France, United States
Repros Therapeutics Inc.

Completed

Extension of Study ZPV-200

Uterine Fibroids

United States
MedImmune LLC

Completed

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

Healthy Subjects

United States
University of Geneva, Switzerland
University of Lausanne

Recruiting

Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies (AMA)

Periodontal Diseases | Pharmacokinetics | Antibiotics

Switzerland
Nocion Therapeutics

Completed

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175

Refractory Chronic Cough

United States
Pfizer

Completed

First Safety Study in Humans of a Single Dose of CPG 52364

Healthy Volunteers

United States
The Stone Research Foundation for Sports Medicine...

Enrolling by invitation

Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

Trauma | Surgery | Complication of Surgical Procedure | Muscle Atrophy | Knee Injuries and Disorders

United States
Eastern Mediterranean University

Completed

Effect Of Meal Frequency On Weight Loss And Body Composition Of Obese And Overweight Women

Overweight and Obesity

Cyprus
GlaxoSmithKline

Completed

Safety and Efficacy Study in Patients With Major Depressive Disorder

Depressive Disorder

Russian Federation
Viridian Therapeutics, Inc.

Not yet recruiting

A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Thyroid Eye Disease

United States
MedImmune LLC

Completed

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

Healthy Volunteer

United Kingdom
GlaxoSmithKline

Completed

First Time in Human Study Using GSK2330672

Diabetes Mellitus, Type 2

United States
Sameem M. Abedin, MD

Recruiting

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

Graft-versus-host Disease

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma

Asthma

United States, Canada
Edwards Lifesciences

Active, not recruiting

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis (EARLY TAVR)

Heart Diseases | Aortic Stenosis, Severe

United States, Canada
Henrik Gudbergsen
Novo Nordisk A/S; Cambridge Weight Plan Limited

Completed

Liraglutide 3 mg for Knee Osteoarthritis (LOSEIT)

Obesity | Osteoarthritis

Denmark
Henrik Gudbergsen

Completed

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (US-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Henrik Gudbergsen

Completed

Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance (IM-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
Parker Research Institute

Completed

Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis

Osteoarthritis, Knee

Denmark
Henrik Gudbergsen

Completed

Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance (BIO-LOSEIT-II)

Obesity | Osteoarthritis

Denmark
MGB Biopharma Limited
Syneos Health

Completed

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

Clostridium Difficile Infection

Canada, United States
aTyr Pharma, Inc.

Completed

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

SARS-CoV-2 (COVID-19) Severe Pneumonia

United States, Puerto Rico
Janssen Research & Development, LLC

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants

Healthy

Belgium
Rigshospitalet, Denmark

Completed

The Features Behind the Beneficial Effects of Interval-walking (aIWS2)

Diabetes Mellitus, Type 2

Denmark
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial

Chronic Hepatitis B

China

Search clinical trials for: MGN-3

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations